Genmab A/S annual free cash flow
2017
2018
2019
Genmab A/S Free Cash Flow (FCF) History (GMAB)
Genmab A/S reported kr1.25B in free cash flow for fiscal 2019, an increase of 32.24% from the previous fiscal year, with a free cash flow margin of 23.24%.
View full Genmab A/S company overviewGenmab A/S free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2019 | 2019-12-31 | kr1.25B | kr304.0M | +32.24% | +23.24% |
| 2018 | 2018-12-31 | kr943.0M | −kr557.0M | −37.13% | +31.17% |
| 2017 | 2017-12-31 | kr1.50B | — | — | +63.42% |
Genmab A/S quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Genmab A/S free cash flow growth trends
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Genmab A/S filings at SEC.gov ↗